Table 4 Univariate associations of variables with immune status among ART-naïve study participants in Addis Ababa, Ethiopia
Variables | CD4 < 200 and/or stages III/IV, AOR (95% CI) | CD4 < 350 and/or stages III/IV, AOR (95% CI) | CD4 < 500 and/or stages III/IV, AOR (95% CI) |
|---|---|---|---|
Gender | |||
Male | 1.00 | 1.00 | 1.00 |
Female | 0.45(0.31–0.67) | 0.49(0.34–0.71) | 0.35(0.22–0.57) |
HIV RNA load (copies/mL) | |||
< 10,000 | 1.00 | 1.00 | 1.00 |
≥ 10,000 | 5.55(3.52–8.77) | 5.00(3.51–7.12) | 5.25(3.49–7.90) |
Hemoglobin conc. (g/dL) | |||
Non-anemic | 1.00 | 1.00 | 1.00 |
Anemic | 3.33(1.96–5.67) | 3.27(1.79–5.98) | 2.80(1.3–6.03) |
Total cholesterol conc. (mg/dL) | |||
> 200 | 1.00 | 1.00 | 1.00 |
≤ 200 | 3.82(1.87–7.81) | 2.27(1.43–3.58) | 2.21(1.40–3.50) |